Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite

Novel antibacterial agents for the treatment of serious Gram-positive infections

By Abbanat Darren   Macielag Mark   Bush Karen  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 379-399

Informa Healthcare

Access to resources Recommend Favorite

In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study

By Bouchillon S.K.   Hoban D.J.   Johnson J.L.   Johnson B.M.   Butler D.L.   Saunders K.A.   Miller L.A.   Poupard J.A.  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 181-196

Elsevier

Access to resources Recommend Favorite

A Re-Emerging Class of Antimicrobial Agents: Streptogramins (Quinupristin/Dalfopristin) in the Management of Multiresistant Gram- Positive Nosocomial Cocci in Hospital Setting

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1075-1081

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances Towards New Anti-Infective Agents that Inhibit Cell Surface Protein Anchoring in Staphylococcus aureus and Other Gram-Positive Pathogens

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 991-1000

Bentham Science Publishers

Access to resources Recommend Favorite